fda declares semaglutide shortage resolved february 2025 of popular weight-loss and diabetes drugs is – NBC New York FDA Ends Semaglutide Shortage Listing,
Description
As a result, several semaglutide-based or related medications specifically aimed at treating severe obesity have become available in recent years
Ozempic, which includes the active ingredient semaglutide, is a prescription medication specifically approved by the FDA for the management of type 2 diabetes
The boxed warning for thyroid C-cell tumors on FDA-approved GLP-1 labels is based on rodent studies, and full labeling for retatrutide and orforglipron will be determined during FDA review
theres a refreshing lack of competition between them outside of the small desire to be the first account to post a new product
Cardiovascular disease risk is also elevated, as are concerns about non-alcoholic fatty liver disease and sleep apnoea
